The biomedical textiles market is driven by the rising healthcare expenditure, population growth, increasing healthcare needs, and advancing medical technologies.
PORTLAND, Ore., Aug. 18, 2023 /PRNewswire/ -- Allied Market Research published a report, titled, "The biomedical textiles market is segmented on the basis of fiber type, fabric type, application, and region. On the basis of fiber type, the market is categorized into non-biodegradable fiber, biodegradable fiber, and others. On the basis of fabric type, the market is categorized into woven, non-woven, and others. On the basis of application, it is divided into implantable, non-implantable, and others): Global Opportunity Analysis and Industry Forecast, 2023-2032". According to the report, the global biomedical textile industry generated $16.6 billion in 2022, and is estimated to reach $30.3 billion by 2032, witnessing a CAGR of 6.2% from 2023 to 2032.
Biomedical textiles have been in routine clinical use to ease healing for a very long time. These are widely used in neurovascular products, orthopedic sutures, orthopedic implants, heart valves, vascular grafts, annuloplasty rings, catheter-based delivery systems, pledgets, small joint repair, tissue scaffolds, scoliosis treatment, cerclage cables, spinal stabilization products, and an array of robotic surgery products.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/12183
Prime determinants of growth
The rising healthcare expenditure, driven by population growth, increasing healthcare needs, and advancing medical technologies, is a significant driver for the biomedical textiles market. In addition, healthcare systems are investing more in advanced medical treatments and technologies, due to which the demand for specialized biomedical textile materials has increased in various medical applications. This factor is anticipated to drive the market during the forecast period. However, the biomedical textiles industry is subject to strict regulatory standards and compliance requirements to ensure patient safety and product efficacy.
Report Coverage & Details:
Report Coverage | Details |
Forecast Period | 2023–2032 |
Base Year | 2022 |
Market Size in 2022 | $16.6 billion |
Market Size in 2032 | $30.3 billion |
CAGR | 6.2 % |
No. of Pages in Report | 317 |
Segments covered | Fabric Type, Fiber Type, Application, And Region. |
Drivers | Emergence of technology in biomedical textiles. Rapid growth of aging population |
Opportunities | Rise in use of biomedical textiles in medical industry |
Restraints | High production cost and complexity in design manufacturing |
The woven fabric type segment to maintain its leadership status throughout the forecast period
Based on fabric type, the woven fabric type segment held the highest market share in 2022, accounting for nearly half of the global biomedical textile market revenue and is estimated to maintain its leadership status throughout the forecast period. Woven fabrics have a long history of use in medical and healthcare applications, and many woven biomedical textiles have already undergone regulatory approvals and meet relevant standards. This regulatory compliance and acceptance facilitate faster adoption and integration of woven fabrics into medical devices and therapies. All these factors are creating the most remunerative opportunities for the market. However, the non-woven fabric segment is projected to manifest the highest CAGR of 6.4% from 2023 to 2032.
Procure Complete Report (317 Pages PDF with Insights, Charts, Tables, and Figures) @
https://bit.ly/3KJTgnb
The biodegradable fiber type segment to maintain its leadership status throughout the forecast period
Based on fiber type, the biodegradable fiber type segment held the highest market share in 2022, accounting for nearly half of the of the global biomedical textile market revenue and is estimated to maintain its leadership status throughout the forecast period. This segment is also projected to manifest the highest CAGR of 6.4% from 2023 to 2032. There is an increasing demand from healthcare professionals, patients, and consumers for more sustainable and environmentally conscious products. Biodegradable fiber-based biomedical textiles can enhance the reputation and market position of healthcare providers and manufacturers by demonstrating their commitment to sustainability and eco-friendly practices. These factors are anticipated to offer most lucrative opportunities for the market.
The implantable application segment to maintain its lead position during the forecast period
Based on application, the implantable segment accounted for the largest share in 2022, contributing to more than half of the global biomedical textile market revenue, and is estimated to maintain its leadership status throughout the forecast period. Biomedical textiles are used in cardiovascular implants such as stents, heart valves, and vascular grafts. Textile-based stents provide support and maintain vessel potency after angioplasty, while textile-covered heart valves and vascular grafts offer durability, biocompatibility, and improved hemodynamics. In addition, Biomedical textiles can be engineered to incorporate drug delivery functionalities. They can be designed to release drugs or therapeutic agents over time, allowing for controlled and localized delivery to specific implant sites. This factor is expected to boost market growth during the forecast period. The non-implantable segment is projected to manifest the highest CAGR of 6.4% from 2023 to 2032.
North America to maintain its dominance by 2032
Based on region, North America held the highest market share in terms of revenue in 2022, accounting for nearly one-third of the global biomedical textile market revenue and is estimated to maintain its leadership status throughout the forecast period. The U.S. is a leading market for surgical procedures, and biomedical textiles are extensively used in surgical drapes, gowns, sutures, and other surgical products. The demand for advanced surgical textiles that offer superior infection control, comfort, and protection drives market growth. Furthermore, Canada emphasizes healthcare innovation, research, and development. The country has a strong presence of academic institutions, research organizations, and industry players that collaborate to develop advanced medical textiles and drive market growth. The Asia-Pacific region is projected to manifest the highest CAGR of 6.8% from 2023 to 2032.
Leading Market Players: -
- SWICOFIL AG
- DSM
- CORTLAND BIOMEDICAL
- POLY-MED INCORPORATED
- BALLY RIBBON MILLS, INC.
- ATEX TECHNOLOGIES INC.
- MEDLINE INDUSTRIES INC.
- B. BRAUN MELSUNGEN AG
- INTEGRA LIFESCIENCES
- ELKEM ASA
The report provides a detailed analysis of these key players in the global biomedical textile market. These players have adopted different strategies such as new product launches, collaborations, expansion, joint ventures, agreements, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
Want to Access the Statistical Data and Graphs, Key Players' Strategies:
https://www.alliedmarketresearch.com/biomedical-textiles-market/purchase-options
Similar Reports:
Agricultural Textiles Market: Global Opportunity Analysis and Industry Forecast, 2021-2031
Antimicrobial Textiles Market: Global Opportunity Analysis and Industry Forecast 2020-2027
Conductive Textiles Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
Textile Enzyme Market: Global Opportunity Analysis and Industry Forecast, 2021-2030
Textile Fabrics Market: Global Opportunity Analysis and Industry Forecast, 2021-2031
Technical Textile Market: Global Historical and Forecast Analysis, 2010-2027
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Allied Market Research Blog: https://blog.alliedmarketresearch.com
Blog: https://www.newsguards.com/
Follow Us on | Facebook | LinkedIn | YouTube |
Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biomedical-textiles-market-to-reach-30-3-billion-globally-by-2032-at-6-2-cagr-allied-market-research-301904551.html
Voltar noticias em Inglês